Other interesting possibilities for the use of nanotechnology, but many still require research; these include bosentan NPs and NPs combined with angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers in the treatment of cerebral blood flow in AD. Here, ACE is linked to Alzheimer disease.